It is wonderful to share that OPTIMISE-AR has just been published in Lancet Oncology! Providing recommendations for the statistical analysis and visualisations of Patient-reported Outcomes in dose-finding trials, the paper is free to access until May via: authors.elsevier.com/c/1mnP55EIIg...

My Pint of Science talk on bayesian statistics and its role in early phase trial design is now available on YouTube!

It was an honour to represent the Alan Turing Institute and @icr.ac.uk at #pint24 last year. I hope it’s a useful resource for those interested.

youtu.be/-471AqKp9bw?...

Delighted to be at the Society for Clinical Trials Annual Meeting this week!
Today I presented the PRO-ADD trial design, and I’m excited to talk about dose-agnostic prior calibration for joint outcome dose-finding designs at Contributed Session 18 - 8am Wednesday.